The B lymphocyte subpopulations producing immunoglobulin (Ig)E and the regulatory T cells modulating this IgE production in normals, and in atopic patients with respiratory allergy, atopic dermatitis, and markedly elevated serum IgE levels (>5,000 ng/ml), were investigated. Peripheral blood lymphocytes (PBL) were separated into T and B cell fractions and the ability of B cells to produce IgE in the presence or absence of pokeweed mitogen (PWM) and/or T cells ws determined. The patients had a circulating population of cells which spontaneously produced up to 6 ng of IgE in vitro (per 4 X 10(5) non-E-rosetting cells) in the absence of T lymphocytes and PWM. PBL from normals did not possess such cells. This IgE synthesis occurred primarily (>75%) over the first 72 h of culture. There was a wide range in their activity between patients and from the same patient studied on repeated occasions (from <300 to 6,000 pg per culture). This spontaneous IgE production was inhibited by PWM (mean inhibition, 37%) or normal T lymphocytes (mean inhibition, 42%). The patients lacked T lymphocytes capable of inhibiting this spontaneous IgE synthesis in 7 of 13 experiments. Functionally distinct B cells were identified in the patients and normals that responded to PWM with IgE production in vitro and required T-helper cell activity. Patients had normal PWM-responsive B cell IgE biosynthetic […] 
A B S T R A C T The B lymphocyte subpopulations producing immunoglobulin (Ig)E and the regulatory T cells modulating this IgE production in normals, and in atopic patients with respiratory allergy, atopic dermatitis, and imarkedly elevated serum IgE levels (>5,000 ng/ml), were investigated. Peripheral blood lymphocytes (PBL) were separated into T and B cell fractions and the ability of B cells to produce IgE in the presence or absence of pokeweed mitogen (PWM) and/or T cells was determined. The patients had a circulating population of cells which spontaneously produced up to 6 ng of IgE in vitro (per 4 x 105 non-E-rosetting cells) in the absence ofT lymphocytes and PWM. PBL from normals did not possess such cells. This IgE synthesis occurred primarily (>75%) over the first 72 h of culture. There was a wide range in their activity between patients and from the same patient studied on repeated occasions (from <300 to 6,000 pg per culture). This spontaneous IgE production was inhibited by PWM (mean inhibition, 37%) or normal T lymphocytes (mean inhibition, 42%). The patients lacked T lymphocytes capable of inhibiting this spontaneous IgE synthesis in 7 of 13 experiments.
Functionally distinct B cells were identified in the patients and normals that responded to PWM with IgE production in vitro and required T-helper cell activity. Patients had normal PWM-responsive B cell IgE biosynthetic activity and T-helper function for these B cells. Suppressor T cell activity for PWM-driven IgE synthesis was also evaluated. Both the normals' and the patients' T lymphocytes provided similar levels of T cell suppressor function for PWM-driven IgE produc- Receivedfor publication 5 September 1979 and in reuised form 6 February 1980. inhibitory T cells at times when the T lymphocytes which suppressed spontaneous IgE production were absent fromn their PBL. INTRODUCTION Immunoglobulin (Ig)E is a class of antibody molecules that is intimately associated with human immediate hypersensitivity disease states (1) . Serum levels of IgE are often elevated in the atopic conditions of allergic rhinitis, allergic asthma, and atopic dermatitis, as well as parasitic infections and a variety of other disorders (2) . Indeed, the range of polyclonal levels for serum IgE is many times greater than any other immunoglobulin class, ranging from <10 to >100,000 ng/ml.
The regulatory events controlling the synthesis of IgE have been extensively studied in rodent models using in vivo and in vitro systems that employ inbred strains and experimental immunization. These studies have shown the overall T cell dependence of IgE antibody production and the homeostatic role of T helper and T suppressor lymphocytes (3) (4) (5) . The previous development of in vitro systems for analysis of human total and antigen-specific IgG, IgM, and IgA has led to both an increased understanding of normal human immune cell function as well as insight into the pathophysiologic mechanisms leading to diseases of immune deficiency, autoimmunity, and lymphoproliferative states (6) . Recently several laboratories, including our own, have adopted in vitro systems for the analysis of production of human IgE in vitro.
Data from these laboratories have yielded what appear to be conflicting results in regard to the role of T lymphocytes and pokeweed mitogen (PWM)' in stim-ulating and regulating B cell IgE production. However, the different investigations have used normals, atopics during their allergy season, and patients with hyperimmunoglobulinemia E.
Our laboratory has recently demonstrated the in vitro identification of functional subpopulations of Ig-producing lymphocytes that differ in their requirements for PWM and T cells (7, 8) . In this study we have undertaken an evaluation of IgE-producing B cell subsets in atopic patients with elevated serum levels of IgE and have shown that one subpopulation is found in the blood of these patients, whereas a second subpopulation is shared by both normals and patients. The existence ofthese subpopulations of B cells and various regulatory T cells affecting their activity clarifies some of the differences seen in vitro IgE synthesis systems.
METHODS
Donors. Blood was obtained from normal donors between the ages of 21 and 35 hr. All normal donors had serum IgE levels <100 IU/ml. Patients with hyperimmunoglobulinemia E (hyper-IgE) were chosen as having serum levels >2,500 IU/ml. All these patients suffered from atopic dermatitis in addition to respiratory allergy. None of the patients had recurrent staphylococcal infection or other findings suggestive of "Hyper-IgE or Buckley Syndrome" (9) and none had received immunotherapy (desensitization).
Lymphocyte preparation and separation procedures. Human peripheral blood lymphocyte (PBL) suspensions were prepared by Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) differential sedimentation (10) of heparinized blood. T (13) .
Radioimmunoassay. The quantitative radioimmunoassay for IgE was performed in microtiter plates (14) . For measurement of IgE produced in culture, microtiter plate wells were filled with monospecific goat anti-human IgE (Research Products International Corp., Elk Grove Village, Ill., Lot 105) at a concentration of 0.5 mg antibody/ml. After incubation in a humidified chamber at 23°C ovemight, the coating antibody solution was removed and saved for reuse. The wells were washed individually three times with 1% bovine serum albumin (BSA) in phosphate-buffered saline, 0.4 M (PBS) and then 10% BSA in PBS was added to the wells for 1 h to saturate any remaining protein-binding surface. After another wash with 1% BSA in PBS, samples to be assayed (350 ,l) were added to wells and allowed to incubate overnight in a humidified chamber at 230C. The following day the samples were removed and discarded. After three more washes with 1% BSA in PBS an IgG fraction of monospecific l25I-labeled (15) goat anti-human IgE (Meloy Laboratories, Inc., Springfield, Va.) was added to each well in a final volume of 300 ,l and allowed to incubate at 23°C for 5 h in a humidified chamber. Thereafter the plates were washed three times 1% BSA in PBS and eight times in running tap water. The individual wells were cut apart and the bound radioactivity was determined. For each radioimmunoassay a seven-point standard curve of IgE was performed in parallel with the culture samples on each plate. The lower limit of sensitivity of this assay is 50 pg per sample or 300 pg per 1.5 ml culture.
The IgE standard was a myeloma protein PS (16) cpm. This serum was diluted to a final concentration of 1:100 DAYS to achieve levels of IgG, IgM, and IgA similar to those produced in culture (100-10,000 ng/ml). were separated by 1 g sedimentation on BSA gradients rang-Identical cultures were also performed in the presence of ing from 1.0 to 2.0%, as described by Miller and Phillips (18) . 50 Atg/ml of cycloheximide (O,O). [1] [2] [3] [4] [5] [6] [7] (Fig. 2) . IgE failed to rise in these cultures.
IgE Production In Vitro in Hyperimmunoglobulin E
The effect of PWM on this spontaneous IgE production was next assessed. In each case where >300 pg of IgE was produced at day 3 without PWM, the addition of PWM caused a fall in the amount of IgE produced by the B cells (mean inhibition of37%) (Table I) . There was no correlation between the percentage of inhibition by PWM and the level of IgE produced in its absence.
Suppressor T cells for spontaneous IgE production. The effect of T lymphocytes on spontaneous IgE production was also evaluated. On eight separate test occasions T lymphocytes (1.6 x 106/culture) were added to B fraction cells (0.14 x 106/culture) in the absence of PWM and the cultures harvested on day 3 (Table IL) . The T lymphocytes were derived from either that patient (autochthonous), another patient, or a normal donor (both allogeneic). Furthermore, parallel cultures were established with irradiated (3,000 rad) T lymphocytes because this treatment has been shown to remove the majority of suppressor T lymphocyte activity (20, 21) . The addition of normal T lymphocytes (seven experimental cultures) consistently inhibited spontaneous IgE production by patients' B cells (Table II) . (Mean 42% and median 40% inhibition with a range of 34 to 60% and a standard deviation of 7.8%.) Irradiation of the normal T lymphocytes removed this suppressor activity (mean 2% inhibition with a range of -23 to +22%). As a group, patients' cells showed significantly less suppression than the normals' (P < 0.01 by two-tailed t test and P < 0.02 by Wilcoxon rank sumn test) with a mean of 22.5% and a median of 25% inhibition with a range of -8 to 42% and a standard deviation of 15.9%. This was a result of the fact that in 7 of the 13 experimental combinations, T cells fromn the patients were significantly less effective (<2 SD) in inhibiting spontaneous IgE production (Table II) .
As cani be seeni in Table II (13) . IgE production occurred to some degree in the presence of medium containing fetal calf serum but was enhanced 4-10-fold by the presence of PWM. Normal and patients' PBL B-fraction cells (0.4 x 106) were placed in 1.5 ml triplicate cultures with or without 1:100 vol/vol PWM. Identical triplicate cultures were also established with untreated or irradiated normnal T lymphocytes from 0.4-4.0 x 106 cells/culture. Fig. 3 shows the kinetics of the IgE production over a 7-d time-course for two such experiments. The normal B cell/T cell cultures showed little IgE production without PWM, whereas with PWM IgE synthesis increased from days 4-7. The B cells from the patients had increased IgE production over days [1] [2] [3] in the absence or presence of PWM (Fig. 3A) . This early synthesis was somewhat diminished by the addition of normal T cells (Fig. 3B) (22) . The amount of IgE produced by the identical B cells in the presence of 1.6 x 106 of the same T cells that had not been irradiated then yields a measure of the irradiation sensitive T suppressor influences present. A suppressor index can be calculated as IgE produced with untreated T cells divided by IgE produced with the irradiated T cells (Table IV) . The greater the suppression, the smaller the index number. The mean index for the normal T cells was 0.63 whereas the mean index for the patients' T cells was 0.64. Two culture pairs (normal subject 4 and patient 7) failed to show any inhibition. The significance of this finding is unknown but we have occasionally observed this previously in the normal population (13) .
Characterizationi of the sponttaneous IgE-produciing 
1462
A. Saxon, C. Morrow, and R. H. Stevens 5 Velocity sedimentation of PBL. Cells (1 x 108) were loaded into 600 ml of a 1-2% gradient of BSA in minimal essential medium. After 3 h at 5°C 15-ml fractions were collected and the distribution of cells determined (x). Larger cells are found in the lower number fractions.
Cultures were established with 1 ml of culture medium without PWM. At day 3, 300-pJ aliquots were removed from each culture and the IgE produced per culture determined (0). release of these lymphoblastoid cells declined sharply 8-10 d after administration of the antigen.
Similar circulating populations of immunoglobulin and antibody-secreting cells have been described in humans. Eby et al. (30) and later Ginsburg et al. (31) detected circulating nonantigen-specific PFC in the PBL of normal individuals not receiving experimental immunization. 8-10 d after immunization with Salmonella typhi, Thompson and Harris (32) detected circulating PFC for salmonella lipopolysaccharide. These studies indicate that circulating PFC are a common occurrence in humans and may be correlated with a recent immune response. Such cells may also be increased in the blood in disorders of altered immune homeostasis such as systemic lupus erythematosis (33) , chronic graft vs. host disease (personal observation), and immunodeficiency with hyper-IgM (34) . We have previously shown that in normal individuals after booster immunization with soluble tetanus toxoid, cells arise in the circulation that are capable of synthesizing appreciable quantities of IgGanti-Tet without PWM stimulation or T cell help (7).
Indeed PWM and un-irradiated T lymphocytes exerted an inhibitory effect on antibody production by these spontaneous antibody-producing cells. Such cells could be functionally distinguished from PWM reactive cells for both IgG and IgM antibodies.
We purposely chose atopic patients with very high serum levels of IgE to see if their PBL contained analogous cells producing IgE. Our data indeed showed the spontaneous production of IgE by these patients' B cells. Furthermore, these cells could also be inhibited by (normal) T cells and PWM. Our failure to detect these cells in our atopic population previously studied may have resulted from the fact that those patients (a) had much lower serum IgE levels, (b) were receiving immunotherapy and repeated parenteral immunization blocks the appearance in the blood of lymphoblastoid B cells (personal observation)2 (c) differ from the patients in the central and eastern United States as our patients are exposed to essentially continuous allergen-pollen exposure in southern California. We noted marked variations in the presence of these cells even in our chosen population with elevated serum IgE levels (Table I ). This probably relates to in vivo events that are stimulating these patients' IgE production but are not understood at this time. By using a PFC assay, Lawrence et al. (35) were unable to demonstrate spontaneous IgE-producing cells in normal PBL but did detect such cells in 5 of 11 normal human bronchial lavage fluids.
The presence of such spontaneous IgE-producing cells in in vitro culture would explain the observations ofTjio et al. (26, 27) We have previously reported on the regulation of these cells in vitro and showed that they are PWM-activated as well as being responsive to T-helper and T cell suppressor influences (13) . Other investigators have not been able to consistently define the presence of these cells. At first Buckley et al. (23) reported stimulation of IgE by PWM in normals. Recently they concluded that PWM did not stimulate normals' IgE production in vitro when they took the mean IgE production of stimulated vs. unstimulated cultures. Analysis of their data reveals that 7 of the 10 normal subjects originally reported had a >50% increase in IgE with PWM and one patient had an 11-fold increase in IgE production. In their latest report (24) We can only speculate why Tjio et al. (26) did not observe this effect. It may well have been because of their use of flat-bottomed culture dishes which would limit cell to cell contact (37) . Such coinditions would prevent the required cell interactions between the rare B and T cell for PWM-induced IgE synthesis where the B cell precursor frequency is very low, -1:50,000 B cells (38) while not affecting the spontaneous IgE production by lymphoblastoid B cells.
The combination of the IgE production by these two B cell populations leads to the biphasic IgE synthesis we observed with patients' B cells plus T cells with FCS as shown in Fig. 2 . PWM lowers the initial IgE (days [1] [2] [3] (7, 32) and appear to represent the dissemination ofan ongoing immune response (39) .
The studies reported herein also provide evidence for at least three functionally distinct populations of T lymphocytes that can regulate in vitro IgE production. One set of PBL T lymphocytes is capable of inhibiting spontaneous IgE production by B cells. These T cells were found uniformly in the normals but their activity was diminished in 7 of 13 of the experimental cultures with patients' T cells. The variable decrease in these cells' function at times from the patients' PBL would explain the variability observed by in suppression of IgE production by T cells in cultures without PWM. Our data demonstrated that the presence of this form of suppressor T activity in the patients' PBL did not correlate with the absence of the spontaneous IgEproducing B cells and vice versa. This is not surprising in that suppressor T cell activity for spontaneous IgG antitetanus activity is present simultaneously with the active B cells in PBL after experimental immunization(s). However, the loss of such suppressor T cell function may be an important reflection of events in lymph nodes or other lymphoid tissue where these lymphoblastoid cells arise and where cellular interactions must occur to regulate their production. Thus the decrease in this form of inhibitory activity in vitro may have important implications for the development of the enhanced IgE in vivo. We do know that normals will not continually regenerate antigenspecific IgG lymphoblastoid cells after repeated immunizations (unpublished observation). Some patients with elevated IgE levels appear to possess isotype E-specific B lymphoblastoid cells in the blood a large proportion of the time. Failure to normally suppress their development could be secondary to loss of the appropriate inhibiting T cell subset.
As in normals, the patients could be demonstrated to have both helper and suppressor T cells that would regulate PWM-induced IgE production. Furthermore, the activity of these separable T cell effects were equivalent in both normals and patients. These results can be understood in the light of our definition of the PWM system as it relates to recent antigen exposure. The PWM-responsive T helper and T suppressor cell subsets arise after the main production of the antibody response in vivo (15) and appear to relate to regulation of some form of possible short term memory. Thus normal activity of these cells would not affect the initial IgE antibody response in the hyper-IgE patients.
The suppressor T cells for PWM-driven IgE synthesis are functionally distinct from the T suppressors of spontaneous B cell IgE synthesis. This was evidenced by the fact that on seven occasions, PBL from patients with hyper-IgE failed to possess the latter type of suppressors but possessed the former.
Thus we have been able to define at least two functional B cell and at least three functional T cell populations that contribute to IgE production in vitro with human PBL (Table V) 
